244 results on '"Rezai K"'
Search Results
2. 3PC-033 Kiro Isolator®: a new, reliable, robotic device for the compounding of injectable anticancer drugs
3. Are IPL home devices really foolproof?
4. Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
5. Iris pigment epithelial cell translocation in exudative age-related macular degeneration: A pilot study in patients
6. A model for xenogenic immune response
7. Human fetal retinal pigment epithelium suppresses the activation of CD4+ and CD8+ T-cells
8. Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study
9. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
10. Dual isotope brain SPECT imaging for monitoring cognitive activation: initial studies in humans
11. A magnetic trap for high-field seeking neutron spin states
12. Myotubular myopathy and excitation contraction coupling: From pathomechanism(s) to therapy
13. A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors
14. P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma
15. Probabilistic mechanics of fibrous structures
16. BET-bromodomain (BRD) inhibitor OTX015: Final results of the dose-finding part of a phase I study in hematologic malignancies
17. Are IPL home devices really foolproof?
18. P.248 - Myotubular myopathy and excitation contraction coupling: From pathomechanism(s) to therapy
19. 431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers
20. 5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies
21. 469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma
22. 587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines
23. 3LBA - A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors
24. 563 Ex Vivo Culture of Fresh Tumor Tissues From Patients Assessing Pharmacodynamic (PD) Markers of OTX008, a Novel Galectin-1 Inhibitor: Relevance to Phase I Trial
25. Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2
26. Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients
27. Incidental lymph node visualization on bone scan due to subcutaneous infiltration of Tc-99m MDP. A potential for false positive interpretation
28. 143 POSTER Ex-vivo plasma protein binding and in vitro evaluation of AP5346 (ProLindac TM; PL), a novel polymer-bound platinum: Evidence showing that >72 h DACH-platinum (Pt) release may play a major role in cytotoxicity
29. Population pharmacokinetics of docetaxel in elderly patients
30. Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study
31. The incidence of serious hemodynamic changes in physically-limited patients following oral dipyridamole challenge before thallium-201 scintigraphy
32. Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
33. Kikuchi-Fujimoto Disease: Hydroxychloroquine as a Treatment
34. Why Don't They Listen? Adherence to Recommendations of Infectious Disease Consultations
35. Human fetal retinal pigment epithelium suppresses the activation of CD4 + and CD8 + T-cells
36. Emission-based attenuation correction of myocardial perfusion studies
37. Comparison of Tight Junction Permeability for Albunim in Iris Pigment Epithelium and Retinal Pigment Epithelium In Vitro.
38. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry.
39. Cranial osteomyelitis: diagnosis and follow-up with In-111 white blood cell and Tc-99m methylene diphosphonate bone SPECT, CT, and MR imaging.
40. Short-term and long-term verbal memory: a positron emission tomography study.
41. Forskolin and Methylxanthines Block the Increase in Intracellular pH During Meiosis in Xenopus laevis Oocytes
42. Protooncogene product, c-mos kinase, is involved in upregulating Na+/H+ antiporter in Xenopus oocytes
43. The Neuropsychology of the Prefrontal Cortex
44. Dual isotope brain SPECT imaging for monitoring cognitive activation
45. MR imaging and HMPAO scintigraphy in conjunction with balloon test occlusion: value in predicting sequelae after permanent carotid occlusion.
46. Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease.
47. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
48. A combined fatigue crack initiation and propagation specimen—its initial development
49. Pränatale Chromosomenbefunde bei sonographisch auffälligen Feten
50. Learning by doing: developing fellows' academic skills through collaborative research.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.